Proto-oncogene receptor tyrosine kinase (ROS1) is activated by chromosomal rearrangement in 1–2% cases of NSCLC [8], consisting of point mutations in the ROS1 gene (e.g., D2033N, G2032R, or L2026M) [34]. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.